Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra
- PMID: 11916484
- DOI: 10.1089/10430340252837206
Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra
Abstract
Somatic cell gene transfer was used to express a mutant form of alpha-synuclein (alpha-syn) that is associated with Parkinson's disease (PD) in the rat substantia nigra (SN), a brain region that, in humans, degenerates during PD. DNA encoding the A30P mutant of human alpha-syn linked to familial PD was incorporated into an adeno-associated virus vector, which was injected into the adult rat midbrain. The cytomegalovirus/chicken beta-actin promoter was used to drive transgene expression. Over a 1-year time course, this treatment produced three significant features relevant to PD: (1) accumulation of alpha-syn in SN neuron perikarya, (2) Lewy-like dystrophic neurites in the SN and the striatum, and (3) a 53% loss of SN dopamine neurons. However, motor dysfunction was not found in either rotational or rotating rod testing. The lack of behavioral deficits, despite the significant cell loss, may reflect pathogenesis similar to that of PD, where greater than 50% losses occur before motor behavior is affected.
Similar articles
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
-
Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.J Neurochem. 2004 Oct;91(2):451-61. doi: 10.1111/j.1471-4159.2004.02728.x. J Neurochem. 2004. PMID: 15447678
-
Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.Nat Med. 1998 Nov;4(11):1318-20. doi: 10.1038/3311. Nat Med. 1998. PMID: 9809558
-
[The mechanism of Lewy body formation in Parkinson's disease].Nihon Rinsho. 2000 Oct;58(10):2022-7. Nihon Rinsho. 2000. PMID: 11068441 Review. Japanese.
-
Synucleins and their relationship to Parkinson's disease.Cell Tissue Res. 2004 Oct;318(1):163-74. doi: 10.1007/s00441-004-0921-7. Epub 2004 Jul 24. Cell Tissue Res. 2004. PMID: 15503152 Review.
Cited by
-
Parkinson's disease: a rethink of rodent models.Exp Brain Res. 2006 Aug;173(2):196-204. doi: 10.1007/s00221-006-0461-3. Epub 2006 Apr 26. Exp Brain Res. 2006. PMID: 16639500 Review.
-
Genetic strategies to study TDP-43 in rodents and to develop preclinical therapeutics for amyotrophic lateral sclerosis.Eur J Neurosci. 2011 Oct;34(8):1179-88. doi: 10.1111/j.1460-9568.2011.07803.x. Epub 2011 Jul 21. Eur J Neurosci. 2011. PMID: 21777407 Free PMC article. Review.
-
Proteome response to the panneural expression of human wild-type alpha-synuclein: a Drosophila model of Parkinson's disease.J Proteome Res. 2008 Sep;7(9):3911-21. doi: 10.1021/pr800207h. Epub 2008 Aug 7. J Proteome Res. 2008. PMID: 18683964 Free PMC article.
-
Gene-environment interactions: key to unraveling the mystery of Parkinson's disease.Prog Neurobiol. 2011 Jun;94(1):1-19. doi: 10.1016/j.pneurobio.2011.03.005. Epub 2011 Mar 23. Prog Neurobiol. 2011. PMID: 21439347 Free PMC article. Review.
-
Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer.Neurobiol Aging. 2010 Dec;31(12):2091-102. doi: 10.1016/j.neurobiolaging.2008.12.002. Epub 2009 Jan 19. Neurobiol Aging. 2010. PMID: 19155101 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
